Close
CDMO Safety Testing 2026
Novotech

CluePoints Appoints Richard Young as Chief Strategy Officer

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

eschbach Unveils Seqonis Intelligent Operations Platform

eschbach has renamed its flagship enterprise software platform, Shiftconnector,...

Agilent, Veeda Lifesciences Launch Biopharma Analytics Hub

Agilent Technologies and Veeda Lifesciences have announced a strategic...

Shilpa Medicare, NXI Therapeutics AG Enters Partnership

A long-term development and commercial manufacturing agreement has been...
- Advertisement -

King of Prussia, PA: RBQM innovatorย CluePointsย has today announced that Richard Young has been appointed as its new Chief Strategy Officer. With 30 years of experience in clinical data management, Richard is an expert in his field.

Richard has previous experience at Medidata, Cmed Group and PAREXEL International. His most recent role was Vice President, Strategy, Clinical Data, at Veeva Systems. Richard has also acted as the Conference Committee Leader for the SCDM Annual Conference for the past three years, and is currently leading their innovations committee.ย His wealth of experience will ensure CluePointsโ€™ continued growth and development as the leading provider of integrated data review software.

Andy Cooper, CEO at CluePoints, commented:ย โ€œAt CluePoints we are committed to innovation and turning data into positive outcomes in clinical trials. Richard has extensive experience of clinical data management and data review, and is a well-regarded expert in his field. His thought leadership is exemplified through his successful podcast series and work on industry forums. Richard sees the journey we are on, our mission to provide the best-in-class integrated data interrogation and risk management platform, and wants to support us on that continued journey.โ€

Richard Youngย reinforced the opportunities on offer:ย โ€œOur industry is living through a digital inflection point, with technology offering us the opportunity to fuel and deliver step changes into global healthcare. Having successfully delivered Veeva Clinical Data, I want to contribute to the next step in realizing the potential for data to reshape and redefine research and development. I believe CluePoints is the perfect place to do that.โ€

Andy Cooper, CEO at CluePoints, added:ย โ€œRichard will drive the strategy for our product portfolio ensuring the value of our products is aligned with our customersโ€™ needs and we are planning, not just for what is needed this year, but what is needed in five yearsโ€™ time. He will ensure we remain a leader in RBQM while also establishing ourselves as the market leader for integrated AI-driven SaaS solutions to analyze and interrogate clinical trial data.โ€

To learn more about CluePointsโ€™ award-winning solutions, please visitย www.cluepoints.com

CluePoints
Company Logo

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

eschbach Unveils Seqonis Intelligent Operations Platform

eschbach has renamed its flagship enterprise software platform, Shiftconnector,...

Agilent, Veeda Lifesciences Launch Biopharma Analytics Hub

Agilent Technologies and Veeda Lifesciences have announced a strategic...

Shilpa Medicare, NXI Therapeutics AG Enters Partnership

A long-term development and commercial manufacturing agreement has been...

Cantex and Headlamp Target MS Depression Using Lumos AI

Cantex Pharmaceuticals and Headlamp Health have entered a collaboration...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป